Tracking Transparency In Clinical Trials: Progress But To What Standard?
Executive Summary
A second survey by the independent NGO Bioethics International shows significant improvement in big pharma’s willingness to share data on clinical trials for important novel drugs. Expectations for further progress remain high, but consensus around a globally consistent, measurable standard is still a long slog.